New vaccine aims to protect against COVID-19 and future coronavirus threats
⭐️ VACCINE ⭐️
Completed
This study tested an experimental vaccine called VBI-2901a in 103 healthy adults aged 18-64 who had already received a COVID-19 vaccine. The vaccine targets three coronaviruses: SARS-CoV-2 (COVID-19), SARS-CoV-1, and MERS-CoV. The goal was to check safety and see if it boosts the…
Phase: PHASE1 • Sponsor: VBI Vaccines Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC